VIR – Vir Biotechnology, Inc.
Vir Biotechnology, Inc.VIR
$5.04Name : Vir Biotechnology, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $696,719,488.00
EPSttm : -4.23
Vir Biotechnology, Inc.
$5.04
2.51%$0.13Float Short %
12.76
Margin Of Safety %
Put/Call OI Ratio
0.3
EPS Next Q Diff
0.14
EPS Last/This Y
0.64
EPS This/Next Y
0.11
Price
5.04
Target Price
17.88
Analyst Recom
1.56
Performance Q
-24.78
Relative Volume
0.7
Beta
1.23
Ticker: VIR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | VIR | 5.07 | 0.30 | 0.13 | 9111 |
| 2025-06-03 | VIR | 5.24 | 0.29 | 0.00 | 9262 |
| 2025-06-04 | VIR | 5.28 | 0.29 | 0.00 | 9298 |
| 2025-06-05 | VIR | 5.16 | 0.29 | 0.07 | 9360 |
| 2025-06-06 | VIR | 5.45 | 0.29 | 0.02 | 9370 |
| 2025-06-09 | VIR | 5.43 | 0.29 | 0.63 | 9327 |
| 2025-06-10 | VIR | 5.43 | 0.29 | 0.11 | 9337 |
| 2025-06-11 | VIR | 5.24 | 0.29 | 0.00 | 9353 |
| 2025-06-12 | VIR | 5.2 | 0.29 | 0.00 | 9366 |
| 2025-06-13 | VIR | 5.21 | 0.29 | 3.00 | 9388 |
| 2025-06-16 | VIR | 5.24 | 0.29 | 0.00 | 9409 |
| 2025-06-17 | VIR | 5.11 | 0.29 | 0.00 | 9442 |
| 2025-06-18 | VIR | 5.21 | 0.29 | 0.85 | 9449 |
| 2025-06-20 | VIR | 5.2 | 0.29 | 0.19 | 9449 |
| 2025-06-23 | VIR | 5.05 | 0.27 | 66.67 | 8513 |
| 2025-06-24 | VIR | 5.26 | 0.30 | 0.03 | 8718 |
| 2025-06-25 | VIR | 5.2 | 0.30 | 0.12 | 8731 |
| 2025-06-26 | VIR | 5.3 | 0.29 | 999.99 | 8791 |
| 2025-06-27 | VIR | 5.16 | 0.30 | 1.24 | 8841 |
| 2025-06-30 | VIR | 5.05 | 0.30 | 0.22 | 8879 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | VIR | 5.08 | 27.9 | - | -3.19 |
| 2025-06-03 | VIR | 5.23 | 27.9 | - | -3.19 |
| 2025-06-04 | VIR | 5.28 | 27.9 | - | -3.19 |
| 2025-06-05 | VIR | 5.15 | 27.9 | - | -3.19 |
| 2025-06-06 | VIR | 5.45 | 27.9 | - | -3.19 |
| 2025-06-09 | VIR | 5.43 | 27.9 | - | -3.19 |
| 2025-06-10 | VIR | 5.43 | 27.9 | - | -3.19 |
| 2025-06-11 | VIR | 5.24 | 27.9 | - | -3.19 |
| 2025-06-12 | VIR | 5.22 | 27.9 | - | -3.19 |
| 2025-06-13 | VIR | 5.21 | 27.9 | - | -3.19 |
| 2025-06-16 | VIR | 5.24 | 27.9 | - | -3.19 |
| 2025-06-17 | VIR | 5.11 | 27.9 | - | -3.19 |
| 2025-06-18 | VIR | 5.21 | 27.9 | - | -3.19 |
| 2025-06-20 | VIR | 5.23 | 27.9 | - | -3.19 |
| 2025-06-23 | VIR | 5.05 | 27.9 | - | -3.19 |
| 2025-06-24 | VIR | 5.27 | 27.9 | - | -3.19 |
| 2025-06-25 | VIR | 5.20 | 27.9 | - | -3.19 |
| 2025-06-26 | VIR | 5.30 | 27.9 | - | -3.19 |
| 2025-06-27 | VIR | 5.17 | 27.9 | - | -3.19 |
| 2025-06-30 | VIR | 5.04 | 27.9 | - | -3.19 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | VIR | -0.32 | 6.06 | 12.28 |
| 2025-06-03 | VIR | -0.33 | 6.06 | 12.28 |
| 2025-06-04 | VIR | -0.33 | 6.06 | 12.28 |
| 2025-06-05 | VIR | -0.33 | 6.06 | 12.28 |
| 2025-06-06 | VIR | -0.33 | 6.06 | 12.28 |
| 2025-06-09 | VIR | -0.33 | 6.07 | 12.28 |
| 2025-06-10 | VIR | -0.33 | 6.07 | 12.28 |
| 2025-06-11 | VIR | -0.33 | 6.07 | 12.93 |
| 2025-06-12 | VIR | -0.33 | 6.07 | 12.93 |
| 2025-06-13 | VIR | -0.33 | 6.07 | 12.93 |
| 2025-06-16 | VIR | -0.33 | 6.08 | 12.93 |
| 2025-06-18 | VIR | -0.33 | 6.08 | 12.93 |
| 2025-06-20 | VIR | -0.33 | 6.08 | 12.93 |
| 2025-06-23 | VIR | -0.33 | 6.10 | 12.93 |
| 2025-06-24 | VIR | -0.33 | 6.10 | 12.93 |
| 2025-06-25 | VIR | -0.33 | 6.10 | 12.93 |
| 2025-06-26 | VIR | -0.33 | 6.10 | 12.76 |
| 2025-06-27 | VIR | -0.33 | 6.10 | 12.76 |
| 2025-06-30 | VIR | -0.33 | 6.10 | 12.76 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.88
Avg. EPS Est. Current Quarter
-0.74
Avg. EPS Est. Next Quarter
-0.74
Insider Transactions
-0.33
Institutional Transactions
6.1
Beta
1.23
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
34
Growth Score
30
Sentiment Score
38
Actual DrawDown %
96.4
Max Drawdown 5-Year %
-94.6
Target Price
17.88
P/E
Forward P/E
PEG
P/S
33.4
P/B
0.67
P/Free Cash Flow
EPS
-4.22
Average EPS Est. Cur. Y
-3.19
EPS Next Y. (Est.)
-3.08
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-2769.04
Relative Volume
0.7
Return on Equity vs Sector %
-79.2
Return on Equity vs Industry %
-60.1
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.18
EBIT Estimation
Vir Biotechnology, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 408
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
stock quote shares VIR – Vir Biotechnology, Inc. Stock Price stock today
news today VIR – Vir Biotechnology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VIR – Vir Biotechnology, Inc. yahoo finance google finance
stock history VIR – Vir Biotechnology, Inc. invest stock market
stock prices VIR premarket after hours
ticker VIR fair value insiders trading